Cargando…

Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes

During the last ten years, transcatheter aortic valve implantation (TAVI) has become a reliable and valid alternative treatment for elderly patients with severe symptomatic aortic valve stenosis requiring valve replacement and being at high or intermediate surgical risk. While common femoral arterie...

Descripción completa

Detalles Bibliográficos
Autores principales: Biasco, Luigi, Ferrari, Enrico, Pedrazzini, Giovanni, Faletra, Francesco, Moccetti, Tiziano, Petracca, Francesco, Moccetti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056625/
https://www.ncbi.nlm.nih.gov/pubmed/30065928
http://dx.doi.org/10.3389/fcvm.2018.00088
_version_ 1783341370939801600
author Biasco, Luigi
Ferrari, Enrico
Pedrazzini, Giovanni
Faletra, Francesco
Moccetti, Tiziano
Petracca, Francesco
Moccetti, Marco
author_facet Biasco, Luigi
Ferrari, Enrico
Pedrazzini, Giovanni
Faletra, Francesco
Moccetti, Tiziano
Petracca, Francesco
Moccetti, Marco
author_sort Biasco, Luigi
collection PubMed
description During the last ten years, transcatheter aortic valve implantation (TAVI) has become a reliable and valid alternative treatment for elderly patients with severe symptomatic aortic valve stenosis requiring valve replacement and being at high or intermediate surgical risk. While common femoral arteries are the access site of choice in the vast majority of TAVI patients, in up to 15–20% of TAVI candidates this route might be precluded due to the presence of diffuse atherosclerotic disease, tortuosity or small vessel diameter. Therefore, in order to achieve an antegrade or retrograde implant, several alterative access routes have been described, namely trans-axillary, trans-aortic, trans-apical, trans-carotid, trans-septal, and trans-caval. The aim of this paper is to give a concise overview on vascular access sites for TAVI, with a particular focus on patient's selection criteria, imaging, technical aspects, and clinical outcome.
format Online
Article
Text
id pubmed-6056625
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60566252018-07-31 Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes Biasco, Luigi Ferrari, Enrico Pedrazzini, Giovanni Faletra, Francesco Moccetti, Tiziano Petracca, Francesco Moccetti, Marco Front Cardiovasc Med Cardiovascular Medicine During the last ten years, transcatheter aortic valve implantation (TAVI) has become a reliable and valid alternative treatment for elderly patients with severe symptomatic aortic valve stenosis requiring valve replacement and being at high or intermediate surgical risk. While common femoral arteries are the access site of choice in the vast majority of TAVI patients, in up to 15–20% of TAVI candidates this route might be precluded due to the presence of diffuse atherosclerotic disease, tortuosity or small vessel diameter. Therefore, in order to achieve an antegrade or retrograde implant, several alterative access routes have been described, namely trans-axillary, trans-aortic, trans-apical, trans-carotid, trans-septal, and trans-caval. The aim of this paper is to give a concise overview on vascular access sites for TAVI, with a particular focus on patient's selection criteria, imaging, technical aspects, and clinical outcome. Frontiers Media S.A. 2018-07-17 /pmc/articles/PMC6056625/ /pubmed/30065928 http://dx.doi.org/10.3389/fcvm.2018.00088 Text en Copyright © 2018 Biasco, Ferrari, Pedrazzini, Faletra, Moccetti, Petracca and Moccetti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Biasco, Luigi
Ferrari, Enrico
Pedrazzini, Giovanni
Faletra, Francesco
Moccetti, Tiziano
Petracca, Francesco
Moccetti, Marco
Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title_full Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title_fullStr Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title_full_unstemmed Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title_short Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
title_sort access sites for tavi: patient selection criteria, technical aspects, and outcomes
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056625/
https://www.ncbi.nlm.nih.gov/pubmed/30065928
http://dx.doi.org/10.3389/fcvm.2018.00088
work_keys_str_mv AT biascoluigi accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT ferrarienrico accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT pedrazzinigiovanni accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT faletrafrancesco accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT moccettitiziano accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT petraccafrancesco accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes
AT moccettimarco accesssitesfortavipatientselectioncriteriatechnicalaspectsandoutcomes